Stopping aspirin 1 to 3 mo after PCI reduces bleeding without increasing MACE vs. continued DAPT

Ann Intern Med. 2020 Dec 15;173(12):JC64. doi: 10.7326/ACPJ202012150-064.

Abstract

O'Donoghue ML, Murphy SA, Sabatine MS. The safety and efficacy of aspirin discontinuation on a background of a P2Y12 inhibitor in patients after percutaneous coronary intervention: a systematic review and meta-analysis. Circulation. 2020;142:538-45. 32551860.

Publication types

  • Comment

MeSH terms

  • Aspirin / therapeutic use
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors* / adverse effects

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin